These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22082711)

  • 21. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between Provider Experience and Cardiac Performance Measures in Outpatients (from the NCDR).
    Carney K; Thande N; Gosch K; Desai N
    Am J Cardiol; 2020 Mar; 125(5):820-826. PubMed ID: 31898968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of heart failure management: a comparison of care between a comprehensive heart failure program and a general cardiology practice.
    Asghar H; Rahko PS
    Congest Heart Fail; 2010; 16(2):65-70. PubMed ID: 20412471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme.
    de Groote P; Isnard R; Clerson P; Jondeau G; Galinier M; Assyag P; Demil N; Ducardonnet A; Thebaut JF; Komajda M
    Eur J Heart Fail; 2009 Jan; 11(1):85-91. PubMed ID: 19147461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.
    de Groote P; Isnard R; Assyag P; Clerson P; Ducardonnet A; Galinier M; Jondeau G; Leurs I; Thébaut JF; Komajda M
    Eur J Heart Fail; 2007 Dec; 9(12):1205-11. PubMed ID: 18023249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
    Fayssoil A
    Indian Heart J; 2010; 62(3):273. PubMed ID: 21275309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of ventricular arrhythmias.
    Aronow WS
    Compr Ther; 2008; 34(2):89-99. PubMed ID: 18833785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart failure.
    McKelvie R
    Clin Evid; 2002 Jun; (7):57-78. PubMed ID: 12230638
    [No Abstract]   [Full Text] [Related]  

  • 29. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality.
    Fonarow GC; Yancy CW; Hernandez AF; Peterson ED; Spertus JA; Heidenreich PA
    Am Heart J; 2011 Jun; 161(6):1024-30.e3. PubMed ID: 21641346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death.
    Boriani G; Valzania C; Diemberger I; Biffi M; Martignani C; Bertini M; Ziacchi M; Domenichini G; Saporito D; Rapezzi C; Branzi A
    Expert Opin Investig Drugs; 2007 May; 16(5):605-23. PubMed ID: 17461735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudden cardiac death in ischemic heart disease.
    Chang D; Goldstein S
    Compr Ther; 1997 Feb; 23(2):95-103. PubMed ID: 9083719
    [No Abstract]   [Full Text] [Related]  

  • 32. [Heart failure due to dilated cardiomyopathy].
    Hiramitsu S; Miyagishima K; Mori K; Kimura H
    Nihon Rinsho; 2007 May; 65 Suppl 5():421-4. PubMed ID: 17569321
    [No Abstract]   [Full Text] [Related]  

  • 33. Electromechanical associations.
    Rogers JG; Cain ME
    N Engl J Med; 2004 May; 350(21):2193-5. PubMed ID: 15152065
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of prophylactic implantable cardioverter-defibrillator implantation in patients with cardiomyopathy.
    Littmann L; Narveson SY; Fesel NM; Marconi SL
    Am J Cardiol; 2012 Jul; 110(1):161-2. PubMed ID: 22704297
    [No Abstract]   [Full Text] [Related]  

  • 36. [Congestive heart failure and arrhythmia].
    Kasanuki H
    Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart failure: early treatment is key.
    Johns Hopkins Med Lett Health After 50; 2006 Jan; 17(11):4-5. PubMed ID: 16444831
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure.
    McKelvie R
    Clin Evid; 2006 Jun; (15):118-39. PubMed ID: 16973007
    [No Abstract]   [Full Text] [Related]  

  • 40. Gaps in Adherence to Guideline-Directed Medical Therapy Before Defibrillator Implantation.
    Fonarow GC; Ziaeian B
    J Am Coll Cardiol; 2016 Mar; 67(9):1070-1073. PubMed ID: 26940928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.